Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals.

IMPORTANCE One approach to understanding the genetic complexity of schizophrenia is to study associated behavioral and biological phenotypes that may be more directly linked to genetic variation. OBJECTIVE To identify single-nucleotide polymorphisms associated with general cognitive ability (g) in people with schizophrenia and control individuals. DESIGN, SETTING, AND PARTICIPANTS Genomewide association study, followed by analyses in unaffected siblings and independent schizophrenia samples, functional magnetic resonance imaging studies of brain physiology in vivo, and RNA sequencing in postmortem brain samples. The discovery cohort and unaffected siblings were participants in the National Institute of Mental Health Clinical Brain Disorders Branch schizophrenia genetics studies. Additional schizophrenia cohorts were from psychiatric treatment settings in the United States, Japan, and Germany. The discovery cohort comprised 339 with schizophrenia and 363 community control participants. Follow-up analyses studied 147 unaffected siblings of the schizophrenia cases and independent schizophrenia samples including a total of an additional 668 participants. Imaging analyses included 87 schizophrenia cases and 397 control individuals. Brain tissue samples were available for 64 cases and 61 control individuals. MAIN OUTCOMES AND MEASURES We studied genomewide association with g, by group, in the discovery cohort. We used selected genotypes to test specific associations in unaffected siblings and independent schizophrenia samples. Imaging analyses focused on activation in the prefrontal cortex during working memory. Brain tissue studies yielded messenger RNA expression levels for RefSeq transcripts. RESULTS The schizophrenia discovery cohort showed genomewide-significant association of g with polymorphisms in sodium channel gene SCN2A, accounting for 10.4% of g variance (rs10174400, P = 9.27 × 10(-10)). Control individuals showed a trend for g/genotype association with reversed allelic directionality. The genotype-by-group interaction was also genomewide significant (P = 1.75 × 10(-9)). Siblings showed a genotype association with g parallel to the schizophrenia group and the same interaction pattern. Parallel, but weaker, associations with cognition were found in independent schizophrenia samples. Imaging analyses showed a similar pattern of genotype associations by group and genotype-by-group interaction. Sequencing of RNA in brain revealed reduced expression in 2 of 3 SCN2A alternative transcripts in the patient group, with genotype-by-group interaction, that again paralleled the cognition effects. CONCLUSIONS AND RELEVANCE The findings implicate SCN2A and sodium channel biology in cognitive impairment in schizophrenia cases and unaffected relatives and may facilitate development of cognition-enhancing treatments.

[1]  Simon C. Potter,et al.  Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.

[2]  R. Reading,et al.  Diagnostic exome sequencing in persons with severe intellectual disability , 2013 .

[3]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[4]  Kelly Schoch,et al.  Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.

[5]  M. Owen,et al.  A population-based study of shared genetic variation between premorbid IQ and psychosis among male twin pairs and sibling pairs from Sweden. , 2012, Archives of general psychiatry.

[6]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[7]  D. Lewis,et al.  NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. , 2012, Schizophrenia bulletin.

[8]  Ian J. Deary,et al.  Genetic contributions to stability and change in intelligence from childhood to old age , 2012, Nature.

[9]  Brita Elvevåg,et al.  Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. , 2011, Schizophrenia bulletin.

[10]  D. Rujescu,et al.  GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia , 2011, Molecular Psychiatry.

[11]  J. Leek,et al.  Temporal dynamics and genetic control of transcription in the human prefrontal cortex , 2011, Nature.

[12]  Michael F. Green,et al.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. , 2011, The American journal of psychiatry.

[13]  P. Thompson,et al.  Heritability of Working Memory Brain Activation , 2011, The Journal of Neuroscience.

[14]  Lorna M. Lopez,et al.  Genome-wide association studies establish that human intelligence is highly heritable and polygenic , 2011, Molecular Psychiatry.

[15]  E. Turkheimer.  Commentary: variation and causation in the environment and genome. , 2011, International journal of epidemiology.

[16]  D. Weinberger,et al.  Neurodevelopmental Origins of Schizophrenia , 2011 .

[17]  K. Hawkins,et al.  The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis , 2011, Neurobiology of Aging.

[18]  Takashi Morihara,et al.  The impact of a genome‐wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[19]  Michael Gill,et al.  Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. , 2010, Archives of general psychiatry.

[20]  M. Meisler,et al.  Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects , 2010, The Journal of physiology.

[21]  D Ongur,et al.  Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder , 2010, Psychological Medicine.

[22]  R. Plomin,et al.  A Three-Stage Genome-Wide Association Study of General Cognitive Ability: Hunting the Small Effects , 2010, Behavior genetics.

[23]  Greg Gibson,et al.  Common genetic variation and performance on standardized cognitive tests , 2010, European Journal of Human Genetics.

[24]  Richie Poulton,et al.  Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. , 2010, The American journal of psychiatry.

[25]  Rainer Goebel,et al.  Genetic Contribution to Variation in Cognitive Function: An fMRI Study in Twins , 2009, Science.

[26]  I. Deary,et al.  Genetic foundations of human intelligence , 2009, Human Genetics.

[27]  S. Dib-Hajj,et al.  Inherited Neuronal Ion Channelopathies: New Windows on Complex Neurological Diseases , 2008, The Journal of Neuroscience.

[28]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[29]  Paul M. Thompson,et al.  Quantifying the heritability of task-related brain activation and performance during the N-back working memory task: A twin fMRI study , 2008, Biological Psychology.

[30]  C. Spencer,et al.  Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.

[31]  Ulrich Ettinger,et al.  Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples , 2008, Archives of general psychiatry.

[32]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[33]  Michael F. Green,et al.  Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. , 2007, Archives of general psychiatry.

[34]  J. Gold,et al.  Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. , 2007, Archives of general psychiatry.

[35]  Ian J Deary,et al.  Premorbid (early life) IQ and later mortality risk: systematic review. , 2007, Annals of epidemiology.

[36]  Birgit Funke,et al.  DTNBP1 genotype influences cognitive decline in schizophrenia , 2007, Schizophrenia Research.

[37]  A. Meyer-Lindenberg,et al.  Intermediate phenotypes and genetic mechanisms of psychiatric disorders , 2006, Nature Reviews Neuroscience.

[38]  David J. Porteous,et al.  The Genetics and Biology of Disc1—An Emerging Role in Psychosis and Cognition , 2006, Biological Psychiatry.

[39]  R. Gur,et al.  A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis , 2006, Schizophrenia Research.

[40]  Richard Coppola,et al.  The G72/G30 Gene Complex and Cognitive Abnormalities in Schizophrenia , 2006, Neuropsychopharmacology.

[41]  Robert K. Heaton,et al.  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. , 2006, The American journal of psychiatry.

[42]  Cameron S Carter,et al.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. , 2005, Schizophrenia bulletin.

[43]  M. Meisler,et al.  Sodium channel mutations in epilepsy and other neurological disorders. , 2005, The Journal of clinical investigation.

[44]  B. Oken,et al.  Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers , 2005, Neurology.

[45]  Michael F. Green,et al.  Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS , 2004, Schizophrenia Research.

[46]  J. Coyle.  The GABA-glutamate connection in schizophrenia: which is the proximate cause? , 2004, Biochemical pharmacology.

[47]  I. Deary,et al.  Early life intelligence and adult health , 2004, BMJ : British Medical Journal.

[48]  R. Gibbs,et al.  Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Tyrone D. Cannon,et al.  A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. , 2003, The American journal of psychiatry.

[50]  Michael F. Green,et al.  Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. , 2003, Schizophrenia bulletin.

[51]  Richie Poulton,et al.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. , 2002, Archives of general psychiatry.

[52]  Michael F Egan,et al.  Relative risk for cognitive impairments in siblings of patients with schizophrenia , 2001, Biological Psychiatry.

[53]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  I. Deary.  Human intelligence differences: a recent history , 2001, Trends in Cognitive Sciences.

[55]  R. Coppola,et al.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.

[56]  Newell,et al.  A neural basis for general intelligence , 2000, American journal of ophthalmology.

[57]  J. Duncan,et al.  Common regions of the human frontal lobe recruited by diverse cognitive demands , 2000, Trends in Neurosciences.

[58]  Michael C. Pyryt.  Human cognitive abilities: A survey of factor analytic studies , 1998 .

[59]  K. Roeder,et al.  The heritability of IQ , 1997, Nature.

[60]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[61]  T. Goldberg,et al.  Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder , 1995, Schizophrenia Research.

[62]  S. Resnick.  Matching for education in studies of schizophrenia. , 1992, Archives of general psychiatry.

[63]  S. Siris,et al.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.

[64]  L. Gottfredson.  What Do We Know About Intelligence , 2016 .

[65]  J. Lieberman,et al.  Genomewide association for schizophrenia in the CATIE study: results of stage 1 , 2009, Molecular Psychiatry.

[66]  Thomas J. Bouchard,et al.  Still just 1 g: Consistent results from five test batteries , 2008 .

[67]  Robert K Heaton,et al.  A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity. , 2004, Schizophrenia bulletin.

[68]  Robert Plomin,et al.  Intelligence: genetics, genes, and genomics. , 2004, Journal of personality and social psychology.

[69]  J. Lieberman,et al.  The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. , 2003, Schizophrenia bulletin.

[70]  J. Callicott,et al.  Brain imaging as an approach to phenotype characterization for genetic studies of schizophrenia. , 2003, Methods in molecular medicine.

[71]  M. First,et al.  Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV) , 2002 .

[72]  Tyrone D. Cannon,et al.  Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. , 2000, Schizophrenia bulletin.

[73]  R. Heinrichs,et al.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.

[74]  A. Jensen,et al.  The g factor , 1996, Nature.